Co-Diagnostics (CODX) Misses Q2 EPS by 7c

Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $500 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• China semiconductor equipment imports grow 9% in July, Barclays comments
• Deere shares climb as fiscal Q3 earnings and revenue top estimates